drugset / Trial / NCT06582732
Performance of the Travoprost Intraocular Implant
Non-randomizedSequentialOpen-labelTreatment
Summary
To evaluate the performance of the Travoprost Intracameral Implant by determining residual drug in explanted implants of the Travoprost Intracameral Implant and by determining aqueous humor concentrations of travoprost free acid at specified timepoints post administration through 24 months
Timeline
- Start
- 2021-03-10
- Primary completion
- 2023-11-02
- Completion
- 2023-11-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Travoprost | Other / unclassified | 75 ug | Other |